Natco Pharma Ltd and its partner Alvogen Inc. have settled a patent infringement case with US drug maker Gilead Sciences Inc., and Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ltd and Genentech Inc., thus clearing the way into the world’s largest pharmaceutical market for the Indian drug maker in terms of launching generic versions of anti-influenza drug, Tamiflu [more].
top of page
Search
Recent Posts
See AllGeneral Motors has secured an Indian patent on a hybrid powertrain control system for vehicles. The patent rights are currently assigned...
00
Taking into consideration the Delhi High court’s order staying the abandonment orders passed by the Trademarks Office, the Registrar of...
00
The order of the Delhi High Court allows the Competition Commission of India (CCI) to attend to complaints on abuse of dominance of...
00
bottom of page
Comments